Pablinny Moreira Galdino

Pablinny Moreira Galdino

Auto-generated profile, based on publicly available information

Pablinny Moreira Galdino

Center for Biological and Health Sciences, Federal University of Western Bahia (UFOB), Barreiras 47810-047, Bahia, Brazil

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2019 in European Journal of Pharmacology
Verified
Journal Article
Closed access
GBGustavo Roberto Villas Boas
Gustavo Roberto Villas Boas
RLRoseli Boerngen de Lacerda
Roseli Boerngen de Lacerda
MPMarina Meirelles Paes
Marina Meirelles Paes
PGPriscila Gubert
Priscila Gubert
WAWagner Luis da Cruz Almeida
Wagner Luis da Cruz Almeida
SOSilvia Oesterreich
Silvia Oesterreich

1 August 2012 in Progress in Neuro-Psychopharmacology and Biological Psychiatry
Verified
Journal Article
Closed access
PGPablinny Moreira Galdino
Pablinny Moreira Galdino
MNMarcus Vinícius Mariano Nascimento
Marcus Vinícius Mariano Nascimento
IFIziara Ferreira Florentino
Iziara Ferreira Florentino
RLRoberta Campos Lino
Roberta Campos Lino
JFJames Oluwagbamigbe Fajemiroye
James Oluwagbamigbe Fajemiroye
ECElson Alves Costa
Elson Alves Costa

1 July 2009 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
PGP.M. Galdino
P.M. Galdino
MNM.V.M. Nascimento
M.V.M. Nascimento
BSBruno Leite Sampaio
Bruno Leite Sampaio
RFR N Ferreira
R N Ferreira
FUFaculdade de Farmácia / UFG
Faculdade de Farmácia / UFG
ECE.A. Costa
E.A. Costa

1 September 2014 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
JMJosé Luis Rodrigues Martins
José Luis Rodrigues Martins
OROscar Romero Lopes Rodrigues
Oscar Romero Lopes Rodrigues
DSDayane Moreira da Silva
Dayane Moreira da Silva
PGPablinny Moreira Galdino
Pablinny Moreira Galdino
JPJosé Realino de Paula
José Realino de Paula
ECElson Costa
Elson Costa

1 June 2016 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
IFIziara F. Florentino
Iziara F. Florentino
DSDaiany P.B. Silva
Daiany P.B. Silva
PGPablinny M. Galdino
Pablinny M. Galdino
RLRoberta C. Lino
Roberta C. Lino
JMJosé Luis Rodrigues Martins
José Luis Rodrigues Martins
ECElson A. Costa
Elson A. Costa

12 February 2021 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
Gustavo Villas-BoasGustavo Villas-Boas
Gustavo Villas-Boas
SLSTEFANIA LAVORATO
STEFANIA LAVORATO
MPMarina Meirelles Paes
Marina Meirelles Paes
PCPablinny M. G. de Carvalho
Pablinny M. G. de Carvalho
VRVanessa C. Rescia
Vanessa C. Rescia
SOSilvia Oesterreich
Silvia Oesterreich
Serotonin (5-HT) receptors are found throughout central and peripheral nervous systems, mainly in brain regions involved in the neurobiology of anxiety and depression. 5-HT receptors are currently promising targets for discovering new drugs for treating disorders ranging from migraine to neuropsychiatric upsets, such as anxiety and depression. It is well described in the current literature that the brain expresses seven types of 5-HT receptors comprising eighteen distinct subtypes. In this article, we comprehensively reviewed 5-HT1-7 receptors. Of the eighteen 5-HT receptors known today, thirteen are G protein-coupled receptors (GPCRs) and represent targets for approximately 40% of drugs used in humans. Signaling pathways related to these receptors play a crucial role in neurodevelopment and can be modulated to develop effective therapies to treat anxiety and depression. This review presents the experimental evidence of the modulation of the “serotonergic receptosome” in the treatment of anxiety and depression, as well as demonstrating state-of-the-art research related to phytochemicals and these disorders. In addition, detailed aspects of the pharmacological mechanism of action of all currently known 5-HT receptor families were reviewed. From this review, it will be possible to direct the rational design of drugs towards new therapies that involve signaling via 5-HT receptors.